Indeed, many original investigations, summarized in later review [4], indicated that LC supplementation lasting up to 4 weeks, neither increase fat oxidation nor improve performance during prolonged exercises
Considered a short acting agent, Exenatide, administered by twice-daily subcutaneous injection, was the first GLP-1 RA in clinical use
C.KoberL
If you inhibit glucagon secretion, you will also make blood glucose go down, because you then inhibit the production of glucose in the body
The medication can potentially increase the risk of recurrent pancreatic inflammation due to its effects on pancreatic enzymes and digestion
Recent research suggests that medications for type 2 diabetes of the GLP-1 class, such as Ozempic or Mounjaro, could offer an additional benefit beyond glycemic control: reduce the risk of dangerous blood clots in people with diabetes.This finding represents a new potential advantage for those who use these treatments